Board Meeting23 Oct 2026, 05:20 pm
Emmessar Biotech Board Meeting on Oct 31, 2026
AI Summary
Emmessar Biotech & Nutrition Ltd has announced that its Board of Directors will convene on October 31, 2026, in Mumbai. The primary agenda item is to consider and approve the unaudited financial results for the quarter ended September 30, 2026. Additionally, in compliance with SEBI regulations, the trading window for the company's equity shares will remain closed until November 02, 2026.
Key Highlights
- Board meeting scheduled for October 31, 2026.
- Unaudited financial results for Q2 FY27 to be approved.
- Trading window closure until November 02, 2026.
- Compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Price Impact
More from EMMESSA